Bertizomeb 3.5mg injection

Buy Bertizomeb 3.5mg Injection (Bortezomib) Online

Bertizomeb 3.5mg contains the active ingredient Bortezomib, a proteasome inhibitor used in the treatment of Multiple Myeloma and Mantle Cell Lymphoma. This high-quality injectable is manufactured by PharmIdea, a pharmaceutical company based in Latvia (European Union), ensuring strict adherence to EU GMP quality standards.

 

Why Choose PharmIdea (Latvia)? Medicines manufactured in the European Union are subject to the world’s strictest quality controls. Bertizomeb offers the same efficacy as the innovator brand (Velcade) but at a more accessible price point.

 

Indications:

• Multiple Myeloma: For patients who have received at least one prior therapy or as a first-line treatment.

• Mantle Cell Lymphoma: For patients who have received at least one prior therapy.

Administration & Storage:

• Route: For Subcutaneous (SC) or Intravenous (IV) use only. FATAL IF GIVEN INTRATHECALLY.

• Storage: Store below 25°C. Keep the vial in the outer carton to protect from light.

• Prescription: A valid prescription from a registered oncologist is strictly required.